Ticker LaunchReverse merger · Completed · INDP
Decoy Biosystems, Inc.
Reverse merger with Intec Pharma Ltd. (via Intec Parent, Inc.)
Decoy Biosystems, Inc. merged into Intec Pharma Ltd. (via Intec Parent, Inc.), a Israeli biopharma holding company that had wound down operations, in a reverse merger that takes the private company public. It closed on Aug 3, 2021. The combined company trades as Indaptus Therapeutics, Inc. (INDP) on Nasdaq.
Indaptus Therapeutics, Inc. is a pre-clinical stage biotechnology company developing a patented, systemically administered immunotherapy for cancer and viral infections.
- Status
- Completed
- Private company
- Decoy Biosystems, Inc.
- Public company
- Intec Pharma Ltd. (via Intec Parent, Inc.)
- Public company business before
- Israeli biopharma holding company that had wound down operations
- Closed
- Aug 3, 2021
- Combined company
- Indaptus Therapeutics, Inc. (INDP)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Concurrent financing and investors
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K Aug 6, 2021
- Closing exhibit
- Announcement 8-K Jul 29, 2021
- All filings on EDGAR CIK 1857044
Other completed reverse mergers
- Stemtech Corporationinto Globe Net Wireless Corp. · Aug 19, 2021
- Tingo Mobile PLCinto IWEB, Inc. · Aug 15, 2021
- HyEdge, Inc.into FICAAR, Inc. · Aug 11, 2021
- Stagwell Media LP (Stagwell Marketing Group)into MDC Partners Inc. · Aug 2, 2021
- Krypto Ventures, Inc.into W Technologies, Inc. · Jul 29, 2021
- Cytocom Inc.into Cleveland BioLabs, Inc. · Jul 28, 2021